Allscripts Healthcare MDRX will be releasing its next round of earnings Thursday. For all of the relevant information, here is your guide for the Q2 earnings announcement.
Earnings and Revenue
Allscripts Healthcare EPS will likely be near 18 cents while revenue will be around $538.16 million, according to analysts.
In the same quarter last year, Allscripts Healthcare posted EPS of 15 cents on sales of $427.7 million. If the company were to match the consensus estimate when it reports Thursday, EPS would be up 20.00 percent. Sales would be up 25.83 percent from the year-ago period. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
| EPS Estimate | 0.17 | 0.18 | 0.16 | 0.15 |
| EPS Actual | 0.16 | 0.18 | 0.16 | 0.15 |
Stock Performance
Over the last 52-week period, shares of Allscripts Healthcare are up 1.14 percent. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The average rating by analysts on Allscripts Healthcare stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Allscripts Healthcare's Q2 conference call is scheduled to begin at 4:30 p.m. ET and can be accessed here: https://edge.media-server.com/m6/p/z5pe287d
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
